Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Merck Tbk. (MERK) vs Sinarmas Multiartha Tbk. (SMMA) Price & Performance

Merck Tbk.Trade
Sinarmas Multiartha Tbk.Trade

Price performance (Past 24H)

Key statistics

Merck Tbk. vs Sinarmas Multiartha Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Sinarmas Multiartha Tbk. trades at Rp20,625 (market cap 131.81T, 200 24h volume). The key difference: Sinarmas Multiartha Tbk. is far larger — about 77.5× Merck Tbk.'s market cap, and Merck Tbk. is more actively traded (37.6K versus 200). Which is the better fit depends on your goals.

MERKSMMA
Market Cap
1.7T131.81T
Volume
37.6K200
Lot
3762
Turnover
144.47M4.13M
Average Price
3,842.2320,625
Value
144.47M4.13M
Indicative Equilibrium Price
3,84020,625
Indicative Equilibrium Volume
72

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MERK
View details
SMMA
View details

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK

About Sinarmas Multiartha Tbk.

PT Sinar Mas Multiartha Tbk was established by Deed No. 60 dated October 21, 1982 from Benny Kristianto, S.H., notary in Jakarta. PT Sinar Mas Multiartha was initially active in commercial leasing, consumer financing and venture capital, and purely became a holding company in the Sinar Mas Group.

Read more on SMMA